outbreak
sever
acut
respiratori
syndrom
sar
affect
individu
respons
almost
death
also
caus
signific
psycholog
econom
impact
worldwid
although
sar
epidem
stop
potenti
threat
sar
remain
high
long
effect
prevent
treatment
sar
avail
spike
protein
sarsassoci
coronavirus
sarscov
interact
cellular
receptor
mediat
infect
target
cell
use
immunoprecipit
li
et
al
identifi
metallopeptidas
angiotensinconvert
enzym
cellular
receptor
sarscov
express
mainli
heart
kidney
also
found
bronchi
lung
major
patholog
sar
resid
rna
interfer
rnai
cellular
process
wherein
short
doublestrand
rna
call
small
interf
rna
sirna
activ
ribonucleas
target
homolog
mrna
use
power
tool
gene
silenc
rnai
also
regard
antivir
strategi
use
plant
probabl
organ
moreov
applic
rnai
technolog
treatment
prevent
infecti
diseas
test
extens
african
green
monkey
kidney
cell
line
vero
express
permit
replic
sarscov
studi
test
hypothesi
rnai
technolog
effect
elimin
cellular
receptor
sarscov
vero
cell
block
sarscov
infect
cell
plasmid
gener
small
hairpin
rna
target
mrna
construct
use
vector
psilenc
neo
ambion
austin
tx
usa
mrna
access
scan
sequenc
pattern
sequenc
analyz
blast
search
genbank
databas
sequenc
contigu
base
pair
homolog
code
sequenc
exclud
two
mutual
complementari
oligonucleotid
encod
small
hairpin
sequenc
target
posit
human
mrna
synthes
anneal
ligat
bamhihindiii
site
psilenc
neo
make
insert
sequenc
confirm
direct
sequenc
african
green
monkey
kidney
cell
vero
purchas
american
type
cultur
collect
manassa
va
usa
cell
line
maintain
minim
essenti
medium
earl
balanc
salt
emem
jrh
bioscienc
lenexa
ks
usa
fetal
bovin
serum
fb
biolog
industri
kibbutz
bet
haemek
israel
vero
cell
cellswel
seed
plate
emem
fetal
calf
serum
day
transfect
order
get
confluenc
transfect
plasmid
transfect
use
lipofectamin
invitrogen
carlsbad
ca
usa
ratio
ug
dna
mix
ul
lipofectamin
per
well
accord
manufactur
instruct
transfect
plasmid
repeat
h
later
cell
subcultur
h
transfect
everi
day
complet
medium
contain
mgml
sigma
st
loui
mo
usa
concentr
reduc
mgml
day
later
cell
dilut
singl
coloni
pick
experi
sarscov
strain
isol
confirm
sar
patient
nation
taiwan
univers
hospit
use
infect
stock
viru
grown
vero
cell
titer
frozen
aliquot
quantit
analysi
sar
replic
experi
cell
grown
confluenc
cell
cultur
plate
inocul
serial
dilut
sarscov
multipl
infect
moi
infect
process
remov
medium
cell
observ
cytopath
effect
moi
sar
virus
inocul
vero
plate
viru
left
ul
emem
fb
h
adsorpt
cell
wash
refe
emem
contain
fb
cytopath
effect
observ
rna
extract
done
differ
time
point
infect
experi
associ
infecti
sarscov
carri
biosafeti
level
laboratori
nation
taiwan
univers
cell
lysat
collet
cell
lysi
buffer
mm
tri
mm
nacl
mm
ethylenediaminetetraacet
premix
proteas
inhibitor
cocktail
tablet
roch
penzberg
germani
resolv
electrophoresi
sdspolyacrylamid
gel
transfer
nitrocellulos
membran
block
done
skim
milk
goat
antibodi
r
system
minneapoli
mn
usa
dilut
use
primari
antibodi
rabbit
antigoat
horseradish
peroxidas
hrp
chemicon
temecula
ca
usa
dilut
use
secondari
antibodi
band
visual
use
enhanc
chemiluminesc
system
perkinelm
boston
usa
quantit
analysi
chemiluminesc
done
use
kodak
imag
station
kodak
imag
analysi
softwar
rochest
ny
usa
express
compar
differ
cell
normal
express
vero
cell
trypsin
wash
bovin
serum
albumin
bsa
sigma
st
loui
mo
usa
phosphatebuff
salin
pb
aliquot
cell
incub
ul
pb
without
ug
antibodi
min
cell
wash
bsapb
incub
fluorescein
isothiocyan
fitc
conjug
rabbit
antigoat
secondari
antibodi
min
cell
fix
formaldehyd
store
analysi
data
acquir
bd
facscalibur
system
analysi
cell
quest
bd
bioscienc
franklin
lake
nj
usa
supernat
cell
cultur
infect
sarscov
use
rna
extract
accord
mini
spin
protocol
qiaamp
viru
rna
mini
kit
qiagen
hilden
germani
extract
rna
elut
rnasefre
water
treat
deoxyribonucleas
life
technolog
carlsbad
ca
usa
digest
genom
dna
store
use
quantit
rtpcr
sarscov
rna
done
use
realart
hpacoronaviru
lc
rtpcr
reagent
artu
biotech
hamburg
germani
lightcycl
instrument
roch
diagnost
mannheim
germani
serial
dilut
sarscov
stock
use
standard
realtim
rtpcr
also
done
quantifi
amount
mrna
primer
pair
extend
two
exon
use
amplifi
amplicon
nucleotid
fluorophor
quencher
duallabel
probe
human
exiqon
vedbaek
denmark
use
roch
lightcycl
roch
diagnost
mannheim
germani
gadph
mrna
also
amplifi
intern
control
use
normal
primer
pair
ctcatgaccacagtccatgc
left
ccctgttgctgtagccaaat
right
neg
strandspecif
revers
transcript
sarscov
rna
carri
ug
total
rna
unit
amv
revers
transcriptas
roch
diagnost
indianapoli
usa
sens
primer
atgaattaccaagtcaatggttac
min
pcr
primer
pair
atgaattaccaagtcaatggttac
cataaccag
tcggtacagcta
bniouta
perform
univers
cycl
condit
min
cycl
lightcycl
roch
diagnost
penzberg
germani
product
visual
ethidium
bromid
stain
separ
agaros
gel
electrophoresi
gadph
mrna
also
amplifi
pcr
intern
control
primer
pair
ctcatgaccacagtccatgc
left
ccctgttgctgtagccaaat
right
two
consecut
lipofectamin
transfect
vero
cell
grew
normal
fig
significantli
reduc
express
western
blot
show
differ
degre
express
variou
clone
clone
reduct
express
western
blot
use
experi
fig
quantit
rtpcr
also
reveal
reduct
mrna
clone
fig
flow
cytometri
confirm
express
significantli
reduc
clone
fig
repeat
western
blot
express
remov
prove
cell
stabli
silenc
data
shown
infect
sarscov
done
vero
cell
parallel
fashion
figur
b
show
morpholog
vero
cell
respect
vero
show
good
suscept
sarscov
almost
vero
cell
round
die
h
inocul
fig
hand
cell
remain
grossli
healthi
h
postinocul
except
foci
typic
cytopath
effect
fig
use
neg
strand
rnaspecif
primer
cdna
neg
strand
rna
sarscov
rna
synthes
amplifi
product
base
pair
size
detect
vero
cell
fig
sarscov
positivestrand
rna
viru
replic
sarscov
requir
synthesi
neg
strand
sarscov
inabl
detect
neg
strand
rna
cell
confirm
lack
sarscov
replic
cell
product
sarscov
compar
vero
cell
determin
sarscov
rna
copi
number
qrtpcr
variou
time
point
inocul
fig
inocul
dose
moi
sarscov
viral
load
increas
robustli
plateau
vero
cell
fig
inocul
dose
decreas
veloc
viral
amplif
also
decreas
inocul
dose
moi
sarscov
replic
significantli
delay
cell
lower
viral
load
demonstr
vero
h
postinfect
howev
viral
load
reach
compar
level
cell
h
postinfect
fig
c
inocul
dose
decreas
moi
viru
replic
cell
h
postinfect
fig
experi
repeat
twice
vari
viral
load
readout
trend
result
shown
fig
repres
two
independ
experi
discoveri
rnai
togeth
develop
method
gener
deliveri
led
potenti
applic
rnai
novel
antivir
approach
report
regard
inhibit
sarscov
rnai
accumul
review
elsewher
use
viral
receptor
coreceptor
target
inhibit
viral
replic
also
test
certain
virus
human
immunodefici
viru
hiv
knowledg
howev
first
studi
test
feasibl
block
sarscov
infect
sirna
target
cellular
receptor
sever
earlier
studi
test
suscept
variou
perman
primari
eukaryot
cell
line
sarscov
mrna
could
detect
suscept
cell
line
abund
correl
sarscov
suscept
hand
refractori
cell
line
made
permiss
sarscov
exogen
express
studi
extend
observ
show
sarscov
suscept
reduc
vero
cell
mrna
reduc
sirna
although
success
silenc
reduct
suscept
sarscov
shown
current
studi
obstacl
exist
clinic
usag
rnaimedi
silenc
prevent
therapeut
modal
sarscov
infect
block
effect
silenc
appear
modest
experi
inocul
dose
moi
viral
load
reach
nearli
normal
level
h
postinocul
fig
c
suggest
low
express
fig
suffici
support
entri
sarscov
particl
adequ
produc
equival
viral
load
h
presenc
cellular
receptor
sarscov
anoth
possibl
explan
failur
block
sarscov
replic
higher
inocul
report
minor
receptor
sarscov
prove
possibl
efficaci
silenc
could
theoret
enhanc
choos
differ
target
use
multiplehit
approach
incorpor
sever
sirna
target
variou
rna
sequenc
sarscov
receptor
time
might
use
synergist
effect
one
sirna
target
differ
gene
sarscov
observ
besid
recent
studi
show
interleukin
il
interferon
ifn
gamma
downregul
express
cell
surfac
inhibit
sarscov
replic
cocktail
approach
coadministr
rnai
nonrnai
strategi
suppress
express
might
maxim
clinic
effect
henc
potenti
therapeut
applic
anoth
concern
translat
current
result
clinic
relev
context
report
essenti
regul
cardiac
function
knockout
mice
show
cardiac
dysfunct
select
elimin
organ
vulner
sarscov
never
test
vivo
could
possibl
lead
unexpect
consequ
summari
sirna
technolog
specif
silenc
cellular
receptor
sarscov
vero
cell
replic
sarscov
reduc
cell
hypothesi
elimin
reduc
block
sarscov
infect
prove
true
howev
consid
modest
effect
observ
concern
rais
appli
sirna
technolog
sar
prevent
therapi
requir
effort
